2-((R)-2-Methylpyrrolidin-2-yl)-1H-benzi midazole-4-carboxamide Crystalline Form 1

Details for Australian Patent Application No. 2008310781 (hide)

Owner Abbott Laboratories

Inventors Kolaczkowski, Lawrence

Agent Spruson & Ferguson

Pub. Number AU-A-2008310781

PCT Pub. Number WO2009/049111

Priority 60/979,643 12.10.07 US

Filing date 10 October 2008

Wipo publication date 16 April 2009

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/4184 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

4 March 2010 PCT application entered the National Phase

  PCT publication WO2009/049111 Priority application(s): WO2009/049111

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008310793-Restraint device for traction sheaves

2008310767-Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis